Pharmacologic ciliary body ablation for chronic glaucoma in dogs: A retrospective review of 108 eyes from 2013 to 2018.

Vet Ophthalmol 2020 Aug 28. Epub 2020 Aug 28.

BluePearl Veterinary Partners, Clearwater, FL, USA.

Objective: To evaluate the long-term outcome and efficacy of intravitreal injection of gentamicin and dexamethasone sodium phosphate (IVGD) or triamcinolone in end-stage glaucoma patients and determine pre-procedure prognostic indicators of success and post-operative complications.

Procedure: Medical records were reviewed for 108 dogs (108 eyes) treated with intravitreal gentamicin with or without dexamethasone sodium phosphate or triamcinolone for glaucoma between 2013 and 2018 with 3 months of minimum follow-up. Signalment and clinical findings, including type of glaucoma, pre-procedure intraocular pressure (IOP), chronicity, procedure protocol, and outcome were recorded. Success was defined as an intraocular pressure of ≤25 mm Hg at the time of last re-examination or no ocular hypotensive medications at 3 months or longer post-injection.

Results: The overall success rate for pharmacologic ablation was 95%. The success rate for dogs receiving no ocular hypotensive medications was 86%. Seventy-six eyes (70.4%) had primary glaucoma, and 32 eyes (29.6%) had secondary glaucoma. Age at the time of injection had no effect on initial success but did in final success (P =-.03) for dogs requiring repeat injections. Cocker Spaniels required the most repeat 2nd and 3rd injections (3/12 dogs) and (2/4 dogs), respectively. No preoperative variable significantly affected the success rate. The most common complications were phthisis bulbi (59.2%), corneal edema (25.9%), and ulcerative keratitis (22.3%). Uncontrolled IOP resulted in enucleation in two dogs (1.8%).

Conclusions: Pharmacologic ablation has a high overall success rate in lowering IOP to ≤25 mm Hg short-term in blind, glaucomatous canine eyes. Type of glaucoma, pre-procedure IOP, chronicity, and protocol did not affect success.

Download full-text PDF

Source Listing
August 2020

Publication Analysis

Top Keywords

success rate
ocular hypotensive
hypotensive medications
2013 2018
type glaucoma
108 eyes
glaucoma pre-procedure
gentamicin dexamethasone
intraocular pressure
pharmacologic ablation
dexamethasone sodium
sodium phosphate
iop chronicity
chronicity procedure
repeat 2nd
2nd 3rd

Similar Publications

Intravitreal cidofovir injection for the management of chronic glaucoma in dogs.

Vet Ophthalmol 2014 May 14;17(3):201-6. Epub 2013 Jun 14.

Center for Animal Referral and Emergency Services, Langhorne, PA, USA.

Objective: The objective of this retrospective study was to determine whether an intravitreal injection of 562.5 ug of cidofovir was effective in lowering the intraocular pressure (IOP) in chronically glaucomatous avisual canine eyes.

Patients: This study reviews the medical records of 167 canine patients diagnosed with chronic glaucoma between 2006 and 2011. Read More

View Article and Full-Text PDF
May 2014

Measurement of plasma gentamicin concentrations postchemical ciliary body ablation in dogs with chronic glaucoma.

Vet Ophthalmol 2016 Jan 17;19(1):57-62. Epub 2015 Feb 17.

Department of Clinical Sciences, Kansas State University, Manhattan, KS, USA.

Objective: To investigate the absorption of gentamicin into the plasma after an intravitreal injection in dogs and to report the success rate of this procedure in lowering the intraocular pressure.

Animals: Twenty-four client-owned dogs with chronic, end-stage glaucoma.

Procedures: Dogs received a unilateral (22) or bilateral (2) intravitreal injection of 25-40 mg of gentamicin (mean ± SD dose 2. Read More

View Article and Full-Text PDF
January 2016

Transvitreal endocyclophotocoagulation.

J A Haller

Trans Am Ophthalmol Soc 1996 ;94:589-676

Purpose: Transvitreal endophotocoagulation of the ciliary processes is a little-used option for eyes with refractory glaucoma. No histopathologic studies of animals or humans have described its effects. We sought to characterize this cilioablative procedure in an animal model, examine its effects in human eyes histopathologically, and evaluate its clinical safety and efficacy in a large series of patients with long-term follow-up. Read More

View Article and Full-Text PDF
March 1997

The effect of intravitreal triamcinolone on intraocular pressure.

Curr Med Res Opin 2007 Jun 25;23(6):1253-8. Epub 2007 Apr 25.

Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.

Objective: To evaluate the effect of triamcinolone acetonide (ITA) on intraocular pressure (IOP) following intravitreal injection, and, in those patients who experience post-injection elevation of IOP, to determine the time course, effect of multiple injections, and risk factors for the pressure rise.

Methods: A retrospective chart review of 85 consecutive patients who received ITA (0.1 mL of 40 mg/mL solution) at the University of Texas South-western Medical Center between January 2002 and April 2004 was performed. Read More

View Article and Full-Text PDF
June 2007